DMCC SPECIALITY CHEMICALS LIMITED has submitted to the Exchange, the financial results for the period ended March 31, 2026.
DMCC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts more than Nifty Microcap 250 and 3.8 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
DMCC Speciality Chemicals reported strong annual performance for FY2026 with standalone revenue of Rs 58,150.46 Lakhs, up 34.8% from Rs 43,123.19 Lakhs in FY2025. Net profit grew 26.9% to Rs 2,733.18 Lakhs (vs Rs 2,153.97 Lakhs), with EPS at Rs 10.96 versus Rs 8.64 prior year. The Board recommended a final dividend of 25% (Rs 2.50 per share). However, operating cash flow turned negative at Rs -1,791.48 Lakhs (vs Rs 3,799.57 Lakhs positive in FY25) due to significant working capital buildup - inventories nearly doubled to Rs 9,189.32 Lakhs and trade receivables rose to Rs 9,594.25 Lakhs. Short-term borrowings increased sharply to Rs 4,962.17 Lakhs. Statutory auditors issued an unmodified (clean) opinion on both standalone and consolidated results.
Strong top-line and bottom-line growth signals healthy business momentum, but the sharp negative operating cash flow and rising working capital requirements warrant monitoring. The dividend declaration is a positive signal for shareholders, though investors should watch if the cash flow situation normalises.